From The Economic Times
Center-Right Owned by Bennett, Coleman & Co.Govt plans instant ban on manufacturing of drugs failing key quality tests
What's behind this
The government is planning an instant ban on manufacturing of drugs that fail key quality tests, with immediate suspension of licences for pharma companies if tests show failure. The health ministry's proposal aims to protect public health by swift action on substandard medications. Regulators would act upon a government analyst's report. The centre has proposed immediate suspension of licences for drugs deemed “Not of Standard Quality” on critical quality parameters, as a major step to strengthen the regulatory framework for medicine quality and safety.
AI-generated overview from 2 outlets. It summarises their reporting and adds no reporting of its own.
What each side is saying
One outlet's own words from each side of the spectrum. Quoted, not summarised.
-
left · 1 outlet
Ministry proposes stricter drug safety rules, including immediate suspension of manufacturing licences for substandard medicines and faster regulatory action
-
center · 1 outlet
The Union ministry of health and family welfare has proposed immediately suspending licences of those drug manufacturers whose products were classified as “not of standard quality” (NSQ) after failing to meet certain specified parameters
-
right · 1 outlet
Pharma companies could have their drug licenses suspended immediately if quality tests indicate failure. The health ministry's proposed changes aim to protect public health by enforcing swift action on substandard medications. Regulators would take action upon receiving a government analyst's report…
RSS excerpt
Pharma companies could have their drug licenses suspended immediately if quality tests indicate failure. The health ministry's proposed changes aim to protect public health by enforcing swift action on substandard medications. Regulators would take action upon receiving a government analyst's report…
